Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profileg
Corinne Faivre-Finn 💙

@finn_corinne

French and European, Prof of Thoracic Radiation Oncology, Researcher, RCTs, phase 1 drug-RT, ePROM, RWE, NIHR Senior Investigator, mother of 2. Views are my own

ID:2582454033

calendar_today04-06-2014 13:54:29

3,9K Tweets

4,4K Followers

404 Following

Tom Roques(@tomroques) 's Twitter Profile Photo

Calling The Royal College of Radiologists members and Fellows at . Please RSVP to join us at our drinks reception on the Sunday evening. And please share this widely with colleagues!

Calling @RCRadiologists members and Fellows at #ESTRO24. Please RSVP to join us at our drinks reception on the Sunday evening. And please share this widely with colleagues!
account_circle
Manchester Cancer Research Centre(@MCRCnews) 's Twitter Profile Photo

don't miss our Season 2 Finale with Prof. Matthew Evison and the wonderful Sally Hayton, a never-smoker with ALK positive lung cancer 🫁

You can watch on YouTube or listen on Spotify and Apple Podcasts, you choose!

Links below 👇

account_circle
Gerard Walls(@gwalls89) 's Twitter Profile Photo

The 1-week countdown to is officially on!

Some highlights for trainees:

1. Dedicated Trainee Session = Wed 1000
2. Reception+Posters = Wed 1830
3. Fun Run = Thurs 0645
4. Oral Posters = Thurs 1700
5. Dinner & Band = Thurs 2000
6. MDT Session on ILD + ctDNA = Fri 1200

The 1-week countdown to #BTOG24 is officially on! Some highlights for trainees: 1. Dedicated Trainee Session = Wed 1000 2. Reception+Posters = Wed 1830 3. Fun Run = Thurs 0645 4. Oral Posters = Thurs 1700 5. Dinner & Band = Thurs 2000 6. MDT Session on ILD + ctDNA = Fri 1200
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

🎉 Big news from The Christie NHS ePROM team Manchester Cancer Research Centre🎉
To date
▶️ >50,000 ePROMs filled in
▶️ >18,000 patients enrolled onto the program
▶️ ePROMs rolled out to 33 disease sites and treatment pathways
▶️ 11 papers published/18 abstarcts

account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Just published in Journal of Clinical Oncology Clin Inf▶️Service Evaluation of MyChristie-MyHealth, an Electronic Patient-Reported Outcome Measure Integrated Into Clinical Cancer Care The Christie NHS Manchester Cancer Research Centre
🔑message▶️importance of ePROM acknowledgement by clinicians
pubmed.ncbi.nlm.nih.gov/38574311/

account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Great to hear that further survival improvements have been reported in LS-SCLC
Can’t wait to see the survival curves!
🙏🏽crucial to recruit to EORTC PRIMALUNG and SWOG Cancer Research Network maverick trials to understand the role of PCI in the IO era
Also eagerly awaiting the results NRG Oncology LU005

account_circle
Dr. David Palma(@drdavidpalma) 's Twitter Profile Photo

We made it! Today we completed accrual for the SABR-COMET-10 trial!

As far as I know, it's the first phase III oligomets trial to complete accrual.

A few thoughts below... 🧵

We made it! Today we completed accrual for the SABR-COMET-10 trial! As far as I know, it's the first phase III oligomets trial to complete accrual. A few thoughts below... 🧵
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

So well deserved Anthony Chalmers 💙 👏
You have made an amazing contribution to the UK and European RT community (and beyond) ESTRO
Looking forward to the celebrations in Glasgow

account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

It was a great debate today against Jonathan Spicer MD PhD
Take home message ▶️this is not a fight. We should work together with the MDT to identify the right treatment for the right patient

account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Thanks ⁦Fiona McDonald⁩ for your very positive discussion of the long term outcomes of the CONVERT trial
▶️importance of collecting long term data
▶️trials integrating IO to CTRT in LS-SCLC are awaited

Thanks ⁦@fifimcdrmh⁩ for your very positive discussion of the long term outcomes of the CONVERT trial #ELCC24 ▶️importance of collecting long term data ▶️trials integrating IO to CTRT in LS-SCLC are awaited
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Great presentation of long term outcomes in the CONVERT trial by ⁦Gerard Walls
▶️1/3 patients alive at 5 yrs
▶️low rates of late toxicity
▶️BD RT remains standard of care in LS-SCLC
The Christie NHS⁩ ⁦Manchester Cancer Research Centre⁩ ⁦⁦⁦⁦Science and Innovation at Cancer Research UK

Great presentation of long term outcomes in the CONVERT trial by ⁦@gwalls89⁩ #ELCC24 ▶️1/3 patients alive at 5 yrs ▶️low rates of late toxicity ▶️BD RT remains standard of care in LS-SCLC ⁦@TheChristieNHS⁩ ⁦@MCRCnews⁩ ⁦⁦⁦⁦@CRUKresearch⁩
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Great discussion of the Rationale 315 study by ⁦Jonathan Spicer MD PhD⁩. He makes a plea to clinical trialists- please integrate the surgical language and consider surgical relevant endpoints in trials

Great discussion of the Rationale 315 study by ⁦@DoctorJSpicer⁩. He makes a plea to clinical trialists- please integrate the surgical language and consider surgical relevant endpoints in trials #ELCC24
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Well done Clara for an excellent and convincing presentation. The PACIFIC regimen was definitely the way to go for the presented stage III bulky N2 case The Christie NHS Manchester Cancer Research Centre

Well done Clara for an excellent and convincing presentation. The PACIFIC regimen was definitely the way to go for the presented stage III bulky N2 case #ELCC24 @TheChristieNHS @MCRCnews
account_circle
Corinne Faivre-Finn 💙(@finn_corinne) 's Twitter Profile Photo

Matthias Guckenberger⁩ challenged the concept of the ‘no fly zone’ in early stage NSCLC treated with SABR
Should we move away from anatomical definitions and focus on safe doses deliverable to OAR?

⁦@Mat_Guc⁩ challenged the concept of the ‘no fly zone’ in early stage NSCLC treated with SABR #ELCC24 Should we move away from anatomical definitions and focus on safe doses deliverable to OAR?
account_circle